The Trump administration awarded a small biosecurity company nearly $40 million to screen for Ebola and other infectious diseases just months after a firm linked to President Donald Trump’s elder sons invested in its parent company, according …
So, it seems like the Trump family has found yet another way to make a buck—or should I say, $40 million? Yes, you read that right. The Trump administration decided to shower XpresTest, a biosecurity company, with nearly $40 million in federal contracts for screening for Ebola and handling disease outbreaks. Because nothing says ‘trustworthy’ like a company linked to the former president’s sons, am I right?
Let’s break this down a bit. XpresTest isn’t just your average company selling hand sanitizer and face masks at inflated prices. No, they specialize in biosecurity, which sounds very official and science-y. They received a hefty chunk of federal funds, not just for their stellar reputation (which, spoiler alert, is tied to the Trump family), but also for screening efforts at U.S. airports. Yes, because nothing screams ‘safety’ like a company that has a direct line to the Trump family.
One of the contracts is aimed at screening travelers at various airports—because we all know that the best way to prevent outbreaks is to make sure no one is sneezing in the terminal. The other contract is focused on the Democratic Republic of Congo. You know, just in case someone decides to take a spontaneous trip to a country with a serious Ebola issue.
Now, let’s talk about the money. This award represents a significant increase from what the company had previously received from the government. It’s almost as if the Trump administration decided that biosecurity was the new hot trend, and they were all in. I mean, who wouldn’t want to invest in a company that has connections to the former president’s offspring?
But here’s the kicker: XpresTest is part of XWELL, which is like the VIP club of companies linked to the Trumps. You can almost imagine the family sitting around a table, high-fiving each other every time a contract comes through. “Hey, we’ve got a new contract! Let’s throw a party!” Because nothing says ‘responsible governance’ like mixing business with family ties.
It’s hard not to roll your eyes at the situation. While the world was battling the COVID-19 pandemic, the Trump family was busy securing contracts that could help them cash in on the fear of disease outbreaks. I mean, who could have predicted that biosecurity would become a hot topic? Oh wait, everyone could.
In conclusion, while the rest of us are just trying to figure out how to survive the latest health crisis, the Trump family is cashing in on it. It’s a classic case of making lemonade out of lemons—or, in this case, making $40 million out of a global health scare. So, here’s to XpresTest and their significant windfall! May they screen wisely and profit handsomely—just like their famous family would want them to.
Inspired by: “Firm Linked to Trump’s Sons Got Nearly $40 Million in Federal Contracts to Screen for Ebola and Oth…” (r/News)